rivaroxaban has been researched along with Choroid-Hemorrhage* in 1 studies
1 review(s) available for rivaroxaban and Choroid-Hemorrhage
| Article | Year |
|---|---|
[Spontaneous choroidal hemorrhage associated with novel oral anticoagulants: A report of two cases and literature review].
New direct oral anticoagulants (DOAC) have been approved for treatment and prevention of some thromboembolic diseases: acute and chronic phase of thromboembolic disease, deep venous thrombosis prophylaxis in orthopedic surgery and prevention of stroke in patients with atrial fibrillation. These molecules are an alternative to heparins and vitamin K antagonists. Among these, rivaroxaban (Xarelto Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Choroid Hemorrhage; Dabigatran; Drugs, Investigational; Female; Humans; Rivaroxaban | 2018 |